NLS Pharmaceutics Ltd (NLSP) Quote

NLSP back to $2.70s +'40%

1:42 PM EST, 12/04/2024 (MT Newswires) -- NLS Pharmaceutics (NLSP) said Wednesday it priced a private placement offering of up to 322,580 common shares at $3.10 per share for gross proceeds of up to $1 million.The company said the initial closing of the offering amounting to $500,000 is expected to take place on or before Jan. 10, 2025.At the election of the buyer, the subsequent closing of $500,000 may happen within 15 days after the receipt of shareholder approval and the common shares trading for at least 10 straight trading days higher than $3.10, corresponding to a premium of about 15%, the company added.NLS plans to use the net proceeds for general corporate purposes.

Central nervous system may be activating fire power low floater $2.80s. Can go any minute 

Nice back to $6s + 100% coming down now $3.75 + 20% . Shaking out shorts 

NLSP.........................https://stockcharts.com/h-sc/ui?s=NLSP&p=W&b=5&g=0&id=p86431144783

NLSP............................................https://stockcharts.com/h-sc/ui?s=NLSP&p=W&b=5&g=0&id=p86431144783

2m floater narcolepsy central nervous disorder this morming $6.40s + 80%

Another low floater up to $5.74 + 62%

Another post split mover.everyday and I play em all 300 shares that’s all it takes to make a few hundred. Hit singles or home runs. My traders do the same. You will never be able to do what I do

Bad call clown, embarrassing call.

NLSP HERE WE GO

NLSP POST SPLIT LOOKS BETTER THAN SEEL

NLSP… Daily psar flipped to the Bullish Buy side, after quite a span of time…
https://schrts.co/nsGsXmAU

.1369 NLSP... insiders own a good 36%, Daily psar kissing to fliP to the Upside, on the doJi...
https://schrts.co/rXTZqrSw

.1369...
NLSP…
"AMENDMENT TO THE
NLS PHARMACEUTICS LTD.
COMMON STOCK PURCHASE WARRANTS

September 16, 2024

“This Amendment No. 1, dated September 16, 2024 (the “Effective Date”), to each of the following four common stock purchase warrants (the “Amendment”), issued by NLS Pharmaceuticals Ltd, a Swiss corporation (the “Company”), and each issued on or about (a) January 29, 2021, to Armistice Capital Master Fund Ltd. (“ACMF” or the “Holder” or the “Investor”) to purchase 500,000 shares of the Company’s common stock, par value CHF 0.02 (“Common Stock”), containing an exercise price of $4.15 per share (the “January 2021 Warrant”); (b) April 25, 2022, to ACMF to purchase 2,163,462 shares of Common Stock, containing an exercise price of $1.04 per share (the “April 2022 Warrant”); (c) March 22, 2024, to AMCF, to purchase 1,750,000 shares of Common Stock, containing an exercise price of $0.25 per share (the “March 2024 Warrant”); and (d) July 1, 2024, to ACMF to purchase 2,500,000 shares of Common Stock, containing an exercise price of $0.24 per share (the “June 2024 Warrant”, and together with the January 2021 Warrant, April 2022 Warrant and March 2024 Warrant, the “Existing Warrants”, and each a “Warrant”).”

https://www.otcmarkets.com/filing/html?id=17845694&guid=G2L-kWrdbxRXB3h
On September 18, 2024, NLS Pharmaceutics Ltd., or the Registrant, convened an extraordinary shareholders’ meeting, or the Meeting. At the Meeting, a quorum was present, and the shareholders of the Registrant approved all agenda items as originally proposed.

The Report on Form 6-K is incorporated by reference into the Registrant’s Registration Statements on Form F-3 (File No. 333-262489, and 333-268690 and 333-269220), filed with the Securities and Exchange Commission, to be a part thereof from the date on which this report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.”"

Daily psar fliP to the bullish side, quickly approaching, as well as the Money Flow approaching green, and the macd ready to cross to the upside: all here, at the lower Keltner and Bolinger Band…
https://schrts.co/skfGHHZa

….

NLSP biggest block of shares, so far for the day to print, happened after hours…

Well the gap filled got me a few

NLSP .1491… at the Lower Bolinger Band with the Williams at -91.97 to Boot…
https://schrts.co/mwYafMmH

NLSP 6/17 gaP…

Open at .1140
High .1528
Low .1127
Close .1483
Volume 51.25 million

8/30 current…
Open .1590
High .1590
Low .1451
Currently .1491
Volume 260.9 thousand currently

Yesterday low .1467

You are Welcome… GidDy uP…

I appreciate the post, I have a small chunk, so I check in for T.A. assistance, so I appreciate your post!

Filled the lower gap from 6/17, and at the lower Bolinger Band, and money flow actually in the GreeN…
https://schrts.co/HqnTuExm

NOT FOR LONG...NO PUN INTENDED...W&L AS ALWAYS

whatever 100% up bro

DILUTION POS....NO CASH!

https://healthstockshub.com/news/nasdaq/nlsp/nls-pharmaceutics-and-kadimastem-announce-binding-term-sheet-to-merge

Re opened

T1 halt….

NLSP… Daily Bullish Engulfing candle…
https://schrts.co/FNDvXita

NLSP 10Q expected JULY 12

NLSP 10Q expected July 5

It had to drop before it pops. I've seen this before. Just wish I'd bought at an even cheaper price

Red to green

NLSPW: Circa 10-minutes ago, the Warrants here hit 400+% up --- then nearly immediately, said weak Warrants CRASHED down to only 97% Up --- VOLATILE SHIT!!!

out waiting for a bounce

agree ...but that news was verry good

How far do the algos run it before running it back into the ground is the question.

These overseas stocks never hold up

NLSP https://x.com/TheBull_Stocks/status/1806300478587687084

needs to break 36s

maybe we break 0.46 today
my finger is on the bottom

9 days ago went from .11 to .46 back to .15 on positive data...

These stocks tend to repeat their history.

In vitro = Petri dish,.not even in mice

I've got a feeling that they'll put some news out.

They've definitely shaken the tree. Possibly a R/S soon. I've learned new trading strategies from turds like this

The tree is shaking right now, but it'll be back up before you know it

Computer generated wash trading. The O/S of about 40M has already been tossed over 6X's today, brazen manipulation. Don't get trapped.

Harpoon $$$$$ white water $$$$ full run ahead $$$$$$$

nlsp..............................https://stockcharts.com/h-sc/ui?s=nlsp&p=W&b=5&g=0&id=p86431144783

NLS Pharmaceutics Announces Publication of New Patent Application for Next-Gen Dual Non-Sulfonamide Orexin Receptor Agonists (DOXA)